ACCESS VASCULAR, INC.

Profile

Company Names

ACCESS VASCULAR, INC.

Addresses

175 MIDDLESEX TURNPIKE, SUITE 1A, BEDFORD, MA 01730

Phone Numbers

781-538-6594

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2015

State Incorporated:

DELAWARE

Total Amount Raised:

$51,790,337.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2023-10-13 
$20,646,440.00 
$31,596,440.00 
$10,950,000.00 
Equity, Debt 
5
2022-10-06 
$0.00 
$10,000,000.00 
$10,000,000.00 
Equity, Debt 
4
2021-02-23 
$19,895,191.00 
$19,895,191.00 
$0.00 
Equity, Debt 
3
2019-08-23 
$5,552,706.00 
$7,257,884.00 
$1,705,178.00 
Equity 
2
2018-05-04 
$1,922,000.00 
$4,005,880.00 
$2,083,880.00 
Equity 
1
2017-08-07 
$3,774,000.00 
$3,774,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
AMINE 
 
BENTALEB 
DIRECTOR
ACCESS VASCULAR, INC.
JAMES 
 
BIGGINS 
EXECUTIVE OFFICER, DIRECTOR
ACCESS VASCULAR, INC.
MICHAEL 
R 
JAFF 
DIRECTOR
ACCESS VASCULAR, INC.
ALEXANDRA 
 
MACLEAN 
DIRECTOR
ACCESS VASCULAR, INC.
LUC 
 
MARENGERE 
DIRECTOR
COLUCID PHARMACEUTICALS, INC.   |  ACER THERAPEUTICS INC.   |  RAPID MICRO BIOSYSTEMS, INC.   |  ACCESS VASCULAR, INC.   |  SARKANA PHARMA, INC.   |  VEKTOR MEDICAL, INC.   |  EGG MEDICAL, INC.
JOSEPH 
 
PELLEGRINO 
DIRECTOR
ACCESS VASCULAR, INC.
JJ 
 
PELLIGRINO 
DIRECTOR
ACCESS VASCULAR, INC.
BRENT 
 
RATZ 
DIRECTOR
ACCESS VASCULAR, INC.
MARC 
 
RIVIERE 
DIRECTOR
CERENIS THERAPEUTICS HOLDING S.A.   |  IMMUNORX PHARMA, INC.   |  ACCESS VASCULAR, INC.   |  EGG MEDICAL, INC.
BRENT 
 
SABIN 
DIRECTOR
ACCESS VASCULAR, INC.
PAUL 
 
SABIN 
DIRECTOR
ACCESS VASCULAR, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-10-30
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2023-10-13 
2022-10-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2022-10-06 
2021-03-09
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2021-02-23 
2019-09-09
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-08-23 
2018-05-16
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-05-04 
2017-08-16
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-08-07 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#